CRH and Lewy body dementia: CRH was decreased in de novo SAA+ Lewy body disease (patients who were not under dopaminergic medication) to a similar extent as in the SAA+ Lewy body disease group (P = 1.4e−03, AUC = 0.77) (Fig. 1B; Supplementary Table 3).